For further studies we suggest to involve complexes 1 and 3 , possessing strongly bound ligands, as suitable model complexes both biologically relevant oxidation states +II and +III, with good solubility in water and biological media
as an add-on to metformin, sulfonylureas, and/or sodium-glucose co-transporter 2 inhibitors (SGLT2 inhibitors) (SURPASS-2, -3, and -4)
According to Eli Lillys SURMOUNT-OSA phase 3 clinical trials, higher doses of Mounjaro (10mg and 15mg) reduced the frequency of these apneic events by as much as 30 events per hour ( 9 )
It often does, and thats normal
This integrated approach aims to maximize weight loss success by providing both medicinal support and behavioral guidance
Journal of Clinical Endocrinology & Metabolism, 2023